Dergiler / SDÜ Tıp Fakültesi Dergisi / 2026 / Cilt: 33 Sayı: 3

Prolactinoma Background in Pituitary Apoplexy in Pregnancy: A Meta-Analytic Evaluation

Gültekin Baş(ÖZEL ÜMİT HASTANESİ)0000-0001-6395-2947
Ahmet Toygar Kalkan(Eskişehir OSmangazi University)0000-0002-9709-1871
Göknur Yorulmaz(Eskişehir Osmangazi University)0000-0001-8596-9344
Sayfa
359–367
Yayın Tarihi
2026-09-24
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Preconception counseling, careful dopa- mine agonist management, and multidisciplinary fol- low-up are crucial for women with pituitary adenomas planning pregnancy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:To systematically review the published cases of preg- nancy-associated pituitary apoplexy and describe the clinical features, tumor types, treatment approaches, and pregnancy outcomes.
📊
Temel Bulgular & Veri:A comprehensive search was performed in PubMed and Google Scholar for studies published between 2000 and 2025 reporting cases of pituitary apoplexy occurring during preg- nancy or the postpartum period.
💡
Sonuç & Katkı:Preconception counseling, careful dopa- mine agonist management, and multidisciplinary fol- low-up are crucial for women with pituitary adenomas planning pregnancy.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2000 Verileri
⚙️Değişkenler:Pituitary apoplexy · Pregnancy · Prolacti- noma

Özet

To systematically review the published cases of preg- nancy-associated pituitary apoplexy and describe the clinical features, tumor types, treatment approaches, and pregnancy outcomes. This systematic review was conducted in accordance with the PRISMA guidelines. A comprehensive search was performed in PubMed and Google Scholar for studies published between 2000 and 2025 reporting cases of pituitary apoplexy occurring during preg- nancy or the postpartum period. Seven studies met the inclusion criteria. Data were analyzed regarding demographic characteristics, tumor type, clinical pre- sentation, treatment approach, and maternal–fetal outcomes. A total of 20 pregnant patients were identified. The mean age was 31.05 ± 5.11 years, and the mean ges- tational age at diagnosis was 26.2 ± 8.8 weeks. Pro- lactinoma was the most common tumor type (70%). Approximately 40% of patients underwent surgical treatment, while the remainder were managed medi- cally. All mothers survived, with neurological improve- ment observed in most cases. Fetal outcomes were generally favorable, and no perinatal mortality was reported. Pregnancy-associated pituitary apoplexy is a rare clinical entity that most often develops in the context of prolactinoma. With appropriate medical or surgical management, maternal and fetal prognoses are gen- erally good. Preconception counseling, careful dopa- mine agonist management, and multidisciplinary fol- low-up are crucial for women with pituitary adenomas planning pregnancy.

Abstract

To systematically review the published cases of preg- nancy-associated pituitary apoplexy and describe the clinical features, tumor types, treatment approaches, and pregnancy outcomes. This systematic review was conducted in accordance with the PRISMA guidelines. A comprehensive search was performed in PubMed and Google Scholar for studies published between 2000 and 2025 reporting cases of pituitary apoplexy occurring during preg- nancy or the postpartum period. Seven studies met the inclusion criteria. Data were analyzed regarding demographic characteristics, tumor type, clinical pre- sentation, treatment approach, and maternal–fetal outcomes. A total of 20 pregnant patients were identified. The mean age was 31.05 ± 5.11 years, and the mean ges- tational age at diagnosis was 26.2 ± 8.8 weeks. Pro- lactinoma was the most common tumor type (70%). Approximately 40% of patients underwent surgical treatment, while the remainder were managed medi- cally. All mothers survived, with neurological improve- ment observed in most cases. Fetal outcomes were generally favorable, and no perinatal mortality was reported. Pregnancy-associated pituitary apoplexy is a rare clinical entity that most often develops in the context of prolactinoma. With appropriate medical or surgical management, maternal and fetal prognoses are gen- erally good. Preconception counseling, careful dopa- mine agonist management, and multidisciplinary fol- low-up are crucial for women with pituitary adenomas planning pregnancy.

🔖

Bu Makaleye Atıf Yap

Baş, G., Kalkan, A. T., Yorulmaz, G. (2026). Prolactinoma Background in Pituitary Apoplexy in Pregnancy: A Meta-Analytic Evaluation. SDÜ Tıp Fakültesi Dergisi, Cilt: 33 Sayı: 3, 359–367. https://doi.org/10.17343/sdutfd.1825323

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (21)

  1. Gheorghe AM, Trandafir AI, Ionovici N, et al. Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET). Biomedicines. 2023 Feb 23;11(3):680. doi: 10.3390/biomedici- nes11030680. PMID: 36979658; PMCID: PMC10044830.
  2. Bi WL, Dunn IF, Laws ER Jr. Pituitary apoplexy. Endocrine. 2015 Feb;48(1):69-75. doi: 10.1007/s12020-014-0359-y. Epub 2014 Jul 26. PMID: 25063308.
  3. Pyrgelis ES, Mavridis I, Meliou M. Presenting Symptoms of Pi- tuitary Apoplexy. J Neurol Surg A Cent Eur Neurosurg. 2018 Jan;79(1):52-59. doi: 10.1055/s-0037-1599051. Epub 2017 Apr 24. PMID: 28437813.
  4. Gheorghe AM, Trandafir AI, Stanciu M, et al. Challenges of Pituitary Apoplexy in Pregnancy. J Clin Med. 2023 May 11;12(10):3416. doi: 10.3390/jcm12103416. PMID: 37240522; PMCID: PMC10219036.
  5. Barkhoudarian G, Kelly DF. Pituitary Apoplexy. Neurosurg Clin N Am. 2019 Oct;30(4):457-463. doi: 10.1016/j.nec.2019.06.001. Epub 2019 Aug 7. PMID: 31471052.
  6. Grand'Maison S, Weber F, Bédard MJ, et al. Pituitary apop- lexy in pregnancy: A case series and literature review. Obstet Med. 2015 Dec;8(4):177-83. doi: 10.1177/1753495X15598917. Epub 2015 Sep 22. PMID: 27512477; PMCID: PMC4935046.
  7. Pivonello R, De Martino MC, Auriemma RS, et al. Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. J Endocrinol Invest. 2014;37:99-112.
  8. Scheithauer BW, Sano T, Kovacs KT, et al. The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc. 1990;65:461-74.
  9. Petersenn S. Pituitary disease management during pregnancy: an overview. Minerva Endocrinol. 2018 Dec;43(4):420-422. doi: 10.23736/S0391-1977.18.02835-3. Epub 2018 Mar 15. PMID: 29546742.
  10. Piantanida E, Gallo D, Lombardi V, et al. Pituitary apoplexy du- ring pregnancy: a rare, but dangerous headache. J Endocrinol Invest. 2014;37(9):789-97.
  11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  12. Falhammar H, Tornvall S, Höybye C. Pituitary Apoplexy: A Retrospective Study of 33 Cases From a Single Center. Front Endocrinol (Lausanne). 2021 Apr 15;12:656950. doi: 10.3389/ fendo.2021.656950. PMID: 33935971; PMCID: PMC8082680.
  13. Galvão A, Gonçalves D, Moreira M, et al. Prolactinoma and pregnan- cy - a series of cases including pituitary apoplexy. J Obstet Gynaecol. 2017 Apr;37(3):284-287. doi: 10.1080/01443615.2016.1233946. Epub 2016 Nov 21. PMID: 27866462.
  14. Kato Y, Ogawa Y, Tominaga T. Treatment and therapeutic stra- tegies for pituitary apoplexy in pregnancy: a case series. J Med Case Rep. 2021 May 27;15(1):289. doi: 10.1186/s13256-021- 02892-5. PMID: 34039424; PMCID: PMC8157460.
  15. Kuhn E, Weinreich AA, Biermasz NR, et al. Apoplexy of mic- roprolactinomas during pregnancy: report of five cases and re- view of the literature. Eur J Endocrinol. 2021 May 24;185(1):99- 108. doi: 10.1530/EJE-21-0145. PMID: 33914699.
  16. Atmaca A, Dagdelen S, Erbas T. Follow-up of pregnancy in acromegalic women: different presentations and outcomes. Exp Clin Endocrinol Diabetes. 2006 Mar;114(3):135-9. doi: 10.1055/s-2005-873004. PMID: 16636980.
  17. Xiao Z, Guo X, Yao Y, et al. Multidisciplinary Management of Pituitary Neuroendocrine Tumors During Pregnancy: Institutio- nal Report. Int J Endocrinol. 2025 May 20;2025:1854208. doi: 10.1155/ije/1854208. PMID: 40433506; PMCID: PMC12116089.
  18. Jemel M, Kandara H, Riahi M, et al. Gestational pituitary apop- lexy: Case series and review of the literature. J Gynecol Obs- tet Hum Reprod. 2019 Dec;48(10):873-881. doi: 10.1016/j.jo- goh.2019.05.005. Epub 2019 May 3. PMID: 31059861.
  19. Bills DC, Meyer FB, Laws ER Jr, et al. A retrospective analy- sis of pituitary apoplexy. Neurosurgery. 1993 Oct;33(4):602-8; discussion 608-9. doi: 10.1227/00006123-199310000-00007. PMID: 8232799.
  20. Randeva HS, Schoebel J, Byrne J, et al. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf). 1999 Aug;51(2):181-8. doi: 10.1046/j.1365- 2265.1999.00754.x. PMID: 10468988.
  21. Briet C, Salenave S, Bonneville JF, et al. Pituitary apoplexy. Endocr Rev. 2015;36(6):622-45. doi: 10.1210/er.2015-1042.